Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes

20255 citationsJournal Articlegold Open Access

Authors

Catherine G. Derington · Outcomes Research Consortium

Amara Sarwal · University of Utah

Guo Wei · University of Utah

Sydney E. Hartsell · University of Utah

Michael J Throolin · University of Utah

Ravinder Singh · University of Utah

McKenna Nevers ·

Abstract

In this comparative effectiveness study in veterans with diabetes, liraglutide, semaglutide, and dulaglutide initiators had similar risks for kidney and cardiovascular outcomes. Head-to-head randomized trials are needed to confirm these findings.

Topics & Keywords

Diabetes Treatment and Management Metabolism, Diabetes, and Cancer Gastric Cancer Management and Outcomes

Publication Details

Published in: JAMA Network Open

Volume 8, Issue 10, pp. e2537297-e2537297

DOI: 10.1001/jamanetworkopen.2025.37297

Field-Weighted Citation Impact: 6.80

Command Palette

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes

Authors

Abstract

Topics & Keywords

Publication Details